Altered T Cell Responses to SARS-CoV-2 Correlate with Neurologic Symptom Severity in Long COVID
Lavanya Visvabharathy(Northwestern University), Igor Korlanik, Jeffrey R. Clark(Northwestern University), Pablo Penaloza‐MacMaster(Northwestern University), Patrick H. Lim(Royal Prince Alfred Hospital), Nicole M. Palacio(Northwestern University), Eric M. Liotta(Northwestern University), Edith L. Graham(Northwestern University), Millenia Jimenez(Northwestern University), George Tachas(Antisense Therapeutics (Australia)), Barbara A. Hanson(Northwestern University), Zachary S. Orban(Northwestern University)
Cited by 3
Related Papers
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
|Annals of Clinical and Translational Neurology|2021|715
Linking peripheral atherosclerosis to blood–brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment
|GeroScience|2024|74
Evolution of neurologic symptoms in non‐hospitalized <scp>COVID</scp>‐19 “long haulers”
|Annals of Clinical and Translational Neurology|2022|71
Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection
|Neurology Neuroimmunology & Neuroinflammation|2022|64